Anne-Laure Meynier

Anne-Laure Meynier has a diverse work experience in the finance and healthcare industries. Anne-Laure began their career as a Summer Intern at JPMorgan Chase & Co. in 2008. Anne-Laure then worked as an Associate at Rothschild from 2009 to 2012. Meynier joined Bridgepoint as an Executive from 2013 to 2014 and subsequently worked as a Corporate Finance Director at Nuage Labs from 2014 to 2015.

In 2015, Meynier joined Apposite Capital, an independent investment firm focused on healthcare, where they held various roles. Anne-Laure started as an Investment Manager from 2015 to 2018, then became an Investment Director from 2018 to 2023, and currently serves as a Partner.

In addition to their role at Apposite Capital, Meynier also serves as an Investor Board Director at i2a, a clinical microbiology market provider since 2021. Anne-Laure is also an Investor Board Director at 1MED SA, a regulatory and clinical consultancy services company in the medical devices field since 2021.

Meynier's experience also includes serving as an Investor Board Director at Swanton Care & Community, a national provider of support services, since 2017. Anne-Laure has also been an Investor Board Director at NIMGenetics, a Spanish genetic diagnostic provider, since 2017.

Earlier in their career, Meynier worked as an Investor Board Observer at MiHomecare, a domiciliary care services provider, from 2017 to 2019.

Overall, Meynier has extensive experience in investment and board advisory roles, with a focus on healthcare and medical devices sectors.

Anne-Laure Meynier attended La Rochefoucauld High School from 1990 to 2000, where they focused on mathematics. After completing their high school education, they pursued a Bachelor of Science degree in Economy at Université Paris Dauphine from 2003 to 2006. Anne-Laure furthered their education at ESCP Europe, where they obtained a Master of Science degree in Accounting and Finance from 2006 to 2009.

In 2009, Meynier briefly attended Bond University, where they studied International Business and Finance.

In terms of certifications, they became a Chartered Financial Analyst (CFA) charterholder from the CFA Institute in June 2015. Meynier also obtained certifications in Skills of Negotiation from the British Private Equity and Venture Capital Association (BVCA) in July 2019, and Non-Executive Directors from THE BRITISH PRIVATE EQUITY AND VENTURE CAPITAL ASSOCIATION in October 2018.